Alerts will be sent to your verified email
Verify Email
JFLLIFE
|
JFL Life Sciences
|
Bharat Immunological
|
Vivimed Labs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
12.26 % | 0.0 | 184.61 % |
|
5yr average Equity Multiplier
|
2.68 | 3.08 | -33.72 |
|
5yr Average Asset Turnover Ratio
|
0.93 | 0.61 | 0.27 |
|
5yr Avg Net Profit Margin
|
5.75 % | -18.38 % | -54.08 % |
|
Price to Book
|
1.56 | 0.91 | 0.0 |
|
P/E
|
13.61 | 0.0 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
138.58 Days | 206.63 Days | 184.52 Days |
|
Inventory Days
|
96.42 Days | 125.06 Days | 244.76 Days |
|
Days Receivable
|
135.23 Days | 61.4 Days | 246.32 Days |
|
Days Payable
|
103.44 Days | 117.81 Days | 159.64 Days |
|
5yr Average Interest Coverage Ratio
|
4.03 | -2.32 | -6.61 |
|
5yr Avg ROCE
|
17.72 % | -44.64 % | -13.87 % |
|
5yr Avg Operating Profit Margin
|
10.31 % | -18.7 % | -26.56 % |
|
5 yr average Debt to Equity
|
0.9 | 0.71 | -13.68 |
|
5yr CAGR Net Profit
|
50.43 % | 23.51 % | -14.97 % |
|
5yr Average Return on Assets
|
5.01 % | -10.1 % | -10.44 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
67.47 % | 59.25 % | 7.77 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 14.8 % |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -13.19 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
JFL Life Sciences
|
Bharat Immunological
|
Vivimed Labs
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|